一个是试点研究，另一个是前瞻性、非随机、无对照试验研究，其中60％的患者能达到眼内压<21 mm Hg，并且不需要青光眼药物治疗。
One was a pilot study, and another was a prospective, non-randomized, non-controlled trial in which IOP <21 mm Hg was able to be achieved in 60% of the patients, without glaucoma medication.
专家组的决定立足于一项历时5年，随访时间为12个月，包含149例肥胖患者的无对照非随机临床试验。
The Panel's decision was based on 12-month data from a 5-year, single-arm, non-randomized trial involving 149 obese individuals.
结果：对皮肤无刺激性，亦无变态反应发生，在消炎和止痛两项试验中，试验组与对照组比较，差异有显著性。
Results: none stimulation to derma, none derma feedback to anomalism, in experiments of anti-inflammation and acesodyne, there was great difference between experimental group and control group.
应用推荐